ARCHIVES

High Cervical Cancer Rates Indicate Access Problems

This article is from The Cancer Letter archive.

Vol. 28 No. 8 | August 26, 2005

Download PDF Visit The Full Archive

Related Articles

FDA Encourages Randomized Trials For Medical Devices.

May 26, 2006

CCI Gets Qualified Approval To Continue

January 18, 1980

Colorado Institutions Vying to Build First Carbon Ion Center in the U.S.

September 26, 2014

1978, ’79 budget Projections By Research Programs

November 25, 1977

FDA Holds Up Another IND; Rauscher, FDA Commissioner Hold “Excellent” Meeting

March 19, 1976

NCI Plans Preclinical Studies Of Endoxifen, A Tamoxifen Metabolite.

August 7, 2009